Patent: 10,005,847

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,005,847

Title:	Anti-HER2 glycoantibodies and uses thereof
Abstract:	The present disclosure relates to a novel class of anti-HER2 monoclonal antibodies comprising a homogeneous population of anti-HER2 IgG molecules having the same N-glycan on each of Fc. The antibodies of the invention can be produced from anti-HER2 monoclonal antibodies by Fc glycoengineering. Importantly, the antibodies of the invention have improved therapeutic values with increased ADCC activity and increased Fc receptor binding affinity compared to the corresponding monoclonal antibodies that have not been glycoengineered.
Inventor(s):	Wong; Chi-Huey (Rancho Santa Fe, CA), Wu; Chung-Yi (New Taipei, TW)
Assignee:	ACADEMIA SINICA (Taipei, TW)
Application Number:	14/723,181
Patent Claims:	see list of patent claims

Details for Patent 10,005,847

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech Inc	HERCEPTIN HYLECTA	trastuzumab; hyaluronidase-oysk	INJECTABLE;SUBCUTANEOUS	761106	001	2019-02-28	⤷ Try it Free	ACADEMIA SINICA (Taipei, TW)	2034-05-27	RX		search
Genentech	HERCEPTIN	trastuzumab	VIAL; INTRAVENOUS	103792	001	1998-09-25	⤷ Try it Free	ACADEMIA SINICA (Taipei, TW)	2034-05-27	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,005,847

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015109180	⤷ Try it Free
World Intellectual Property Organization (WIPO)	2015184001	⤷ Try it Free
World Intellectual Property Organization (WIPO)	2015184002	⤷ Try it Free
World Intellectual Property Organization (WIPO)	2015184004	⤷ Try it Free
World Intellectual Property Organization (WIPO)	2015184008	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.